Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 16.38
+0.82 (5.27%)
Apr 1, 2026, 5:30 PM CET
SWX:SANN Market Cap
SWX:SANN has a market cap or net worth of 216.7 million as of April 1, 2026. Its market cap has increased by 15.00% in one year.
Market Cap
216.70M
Enterprise Value
239.52M
Revenue
49.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.38
Market Cap Chart
Since November 3, 2006, SWX:SANN's market cap has decreased from 357.28M to 216.70M, a decrease of -39.35%. That is a compound annual growth rate of -2.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 216.70M | 28.64% |
| Dec 30, 2025 | 168.45M | 0.68% |
| Dec 30, 2024 | 167.31M | 85.24% |
| Dec 29, 2023 | 90.32M | 19.92% |
| Dec 30, 2022 | 75.32M | 34.92% |
| Dec 30, 2021 | 55.82M | 3.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 835.00M |
| Basilea Pharmaceutica AG | 646.54M |
| Newron Pharmaceuticals | 310.67M |
| BioVersys AG | 169.59M |
| Xlife Sciences AG | 118.24M |
| Molecular Partners AG | 117.47M |
| EvoNext Holdings | 5.91M |
| Addex Therapeutics | 5.13M |